ALPHATEC HOLDINGS INC. Logo
US02081G2012
A2AP5V
ATEC

ALPHATEC HOLDINGS INC.

Kurser indlæses...

Prognose

Analytikernes gennemsnitlige kursmål er 11,85 € (+83,15 %). Medianen er 11,39 € (+76,04 %).

Køb
  17
Behold
  3
Sælg
  1

Diskussioner i communityet

Der er endnu ingen diskussion om dette aktiv.

Start diskussion

  • Alphatec Holdings: CEO makes $1 million insider purchase, revenue and EBITDA significantly increased

    Alphatec Holdings reports Q2 revenue rose 15% to $213.5 million and EBITDA grew 53% to $36 million, driven by 20% more cases performed by surgeons. The company highlights its complete solution for more precise and faster spinal surgeries. Full-year revenue is expected to be $882 million. The CEO personally invested $1 million, putting short positions under pressure. » Mere på finanzen.net


  • Alphatec Holdings: CEO purchase triggers short squeeze and stock rises about 20%

    CEO Patrick Miles bought $1.01 million of his own shares near the 52-week low. High short interest led to covering, causing the stock to rise by nearly 20% on September 11, 2026 on increased volume. The company reports 15% revenue growth and positive free cash flow. » Mere på finanzen.net


  • Alphatec Holdings: CEO buy near 52-week low sends stock sharply higher

    Alphatec Holdings' stock rose about 19% in afternoon trading after CEO Patrick Miles purchased 115,000 shares worth roughly $1.01 million at a weighted average price of $8.81. The purchase was made near the 52-week low and is seen as a strong insider vote of confidence, which, together with high short interest, contributed to a short squeeze. The company also recently reported a 15% revenue increase to $213.5 million, positive free cash flow, and reaffirmed its full-year guidance of around $882 million, while US markets overall showed a recovery. » Mere på de.investing.com


  • Alphatec confirms growth model and full-year targets at Wells Fargo conference

    Alphatec said procedure volume was about 20% higher in the first half and reaffirmed its 2026 forecast of $882 million revenue, $140 million EBITDA and $20 million free cash flow. Management cited increasing surgeon adoption, EOS robotics, software and the Theradaptive acquisition as the main growth drivers, but acknowledged near-term pressure from lower revenue per procedure and reduced follow-up rates for biologics. For 2027 the company is targeting $1 billion in revenue, roughly 18% EBITDA margin and $65 million free cash flow, and sees further upside from margin improvements. Alphatec expects rising surgeon acceptance and product penetration to support long-term growth of 15–20% annually. » Mere på de.investing.com


  • Alphatec posts Q1 revenue and surgical volume gains, secures cheaper debt and issues 2026 guidance

    Alphatec reported Q1 2026 total revenue of $192 million, with surgical revenue up 17% and surgical case volume rising 21%; non-GAAP adjusted EBITDA reached $21 million and trailing twelve-month free cash flow was $7 million. The company secured a new bank facility that cuts annual interest expense by over $6 million and extends debt maturities to 2031, ending the quarter with $140 million in cash. For full-year 2026 Alphatec guides total revenue of about $882 million (≈15% growth), surgical revenue near $805 million, adjusted EBITDA around $134 million (15% of revenue) and at least $20 million in free cash flow. » Mere på finance.yahoo.com

Virksomhedstal

I det seneste kvartal havde ALPHATEC HOLDINGS INC. en omsætning på 195,26 mio. € og et nettoresultat på -4,83 mio. €
(EUR) september 2026
YoY
Omsætning 195,26 mio. 16,61 %
Bruttofortjeneste 139,71 mio. 19,41 %
Nettoresultat -4,83 mio. 80,17 %
EBITDA 20,85 mio. 414,89 %

Fundamentale data

Nøgletal Værdi
Markedsværdi
981,19 mio. €
Antal aktier
155,14 mio.
Højeste/laveste i 52 uger
21,22 € - 6,11 €
Udbytte Nej
Beta
0,78
P/E (PE Ratio)
-12,39
PEG (PEG Ratio)
-0,18
K/I (PB Ratio)
51,27
P/S (PS Ratio)
1,28

Virksomhedsprofil

Alphatec Holdings, Inc. er et medicinteknologisk selskab, der designer, udvikler og videreudvikler teknologier til kirurgisk behandling af rygsøjlelidelser. Selskabet tilbyder SafeOp Neural InformatiX System, en Alpha InformatiX-produktplatform designet til at reducere risikoen for intraoperativ nerveskade; Sigma transforaminal lumbar interbody fusion pedicle-based access system, der giver direkte visualisering af anatomiske landemærker; Sigma PTP Access and Patient Positioning System; squadron lateral retractor, designet til at maksimere patienternes resultater; Invictus Spinal Fixation System, et thorakolumbalt fikseringssystem til behandling af en række patologier; og Invictus MIS SingleStep System, der muliggør minimalt invasiv placering af pedikelskruer. Selskabet tilbyder også Invictus Modular Fixation Systems, designet til at øge tilpasningsevnen med kraften i skrue-modularitet; OsseoScrew-systemet til at genoprette rygsøjlens integritet; Arsenal spinal fixation system, en omfattende thorakolumbal fikseringsplatform til at fiksere en række lidelser og kirurgiske indgreb, fra degenerative til deformitetsrelaterede; Aspida Anterior Lumbar Plating System, et fikseringssystem til anterior lumbal interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; og Insignia Anterior Cervical Plate System. Derudover tilbyder selskabet IdentiTi Porous Ti, Transcend Lateral og Battalion Posterior Interbody Implants samt biologiske produkter bestående af Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix og Amnioshield Amniotic Tissue Barrier, samt EOS-billeddiagnostiske produkter. Selskabet sælger sine produkter gennem et netværk af uafhængige distributører og direkte salgsrepræsentanter i USA. Selskabet blev grundlagt i 1990 og har hovedkontor i Carlsbad, Californien.

Navn
ALPHATEC HOLDINGS INC.
CEO
Patrick S. Miles
Hjemsted Carlsbad, ca
USA
Websted
Sektor
Cykliske forbrugsvarer
Branche
Forbrugsgoder
Børsnotering
12.06.2006
Medarbejdere 913

Tickersymboler

Børs Symbol
NASDAQ
ATEC
Frankfurt
L1Z1.F
Düsseldorf
L1Z1.DU
München
L1Z1.MU
🍪

Parqet  bruger cookies. Læs mere